Potentially fatal severe brady arrythmias related to Lopinavir-Ritonavir in a COVID 19 patient

類似資料

• Recurrent oedema associated with the co-formulation of lopinavir and ritonavir Edema recorrente associado à co-formulação de lopinavir e ritonavir
  著者:: Jorge Francisco C. Pinto, 等
  出版事項: (2004-08-01)
• Toxicity for warfarine switching from lopinavir/ritonavir to dolutegravir
  著者:: Ana Pelufo-Pellicer, 等
  出版事項: (2017-03-01)
• The effect of lopinavir - ritonavir on mortality in COVID-19 pneumonia
  著者:: Muhammed Emin Demirkol, 等
  出版事項: (2024-10-01)
• COVID-19 Hastalarında Lopinavir/Ritonavir ve Favipravir Deneyimi
  著者:: Esma Eroğlu, 等
  出版事項: (2020-12-01)
• The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
  著者:: V. B. Denisenko,, 等
  出版事項: (2018-12-01)